Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Detection and Classification of Colon Polyps

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00825292
Recruitment Status : Completed
First Posted : January 21, 2009
Last Update Posted : January 21, 2009
Sponsor:
Information provided by:
Mayo Clinic

Brief Summary:

Colon cancer is the third most common cancer in western society. To prevent colon cancer it is recommended for people to undergo a screening colonoscopy at the age of fifty. The purpose of the colonoscopy is to remove polyps, since some of these lesions are precancerous. Precancerous polyps are called adenomas. This method of prevention is effective, but the standard colonoscopy currently used does not detect all polyps. Studies have reported a polyp miss rate of about 24%. Furthermore, we are unable to distinguish precancerous polyps from benign polyps, also known as hyperplastic polyps, with standard colonoscopy. This results in all polyps being removed at time of colonoscopy, even the benign polyps.

To help improve the detection of colon polyps new endoscopic technologies have been developed. These technologies include high definition white light (HDWL)and high definition narrow band imaging (HDNBI). HDWL improves the overall resolution of the images seen during colonoscopy. HDNBI can help us better classify polyps by enhancing their tissue appearance as well as seeing small blood vessels and capillaries.

The goal of this study to determine if HDNBI imaging shows an increased polyp detection rate when compared to the current standard colonoscopy. In addition to develop a classification system to help better differentiate between precancerous polyps and their benign counterparts using HDWL and HDNBI.


Condition or disease Intervention/treatment Phase
Colon Polyps Procedure: Polp removal and identification Procedure: colon polyp removal Procedure: ETMI colonoscope (ETMI scope is a FDA approved device) Phase 2

  Hide Detailed Description

Detailed Description:

II. Hypothesis:

  1. The use of NBI colonoscopy will reduce the miss rate for colon polyps compared to standard white light imaging.
  2. HDWl and HDNBI are more accurate than standard colonoscopy for the classification of adenomatous polyps in comparison to other non-premalignant polyps.

III. Specific Aims:

  1. Compare the miss rate of standard white light imaging compared to NBI for detection of colon polyps with NBI
  2. Estimate the accuracy of standard white light, HDWL and HDNBI imaging modes for the classification of adenomatous (premalignant) versus non-adenomatous (hyperplastic, inflammatory, normal) polyps.
  3. Examine the inter-observer agreement for classification of adenomatous versus non-adenomatous polyps based on standard, NBI and HDWL imaging.

IV. Research Design and Methods:

4.1 Study Design: A prospective phase II cross-over trial. Patients will undergo both procedures (standard, NBI) back to back under conscious sedation. The order of the procedure will be randomized.

4.2 Setting: The study will take place at Mayo Clinic Jacksonville, Division of Gastroenterology, an expert center in the diagnosis and treatment of colon polyps.

4.3 Study Subjects All patients scheduled for colonoscopy at Mayo Clinic Jacksonville will be screened for eligibility using inclusion and exclusion criteria. The patients that are deemed eligible will be offered participation in the study. Informed consent will be obtained and the participant will be registered in our database. Prior to consent the participant will be made aware of the investigative nature of the study, alternatives, risks, and benefits.

4.4 Eligibility Criteria

Inclusion Criteria:

  1. Age 18 years or older.
  2. Informed written consent.

Exclusion Criteria:

  1. History of inflammatory bowel disease.
  2. Patients with severe cardiopulmonary disease precluding colonoscopy.
  3. Presence of conditions not allowing for polypectomy or biopsy (e.g. coagulation disorder).
  4. Known familial polyposis syndrome (FAP, HNPCC, Juvenile polyposis, etc)
  5. Sub-optimal preparation for the procedure, which will be determined by patient history or based on the initial colonoscopy.
  6. Pregnancy

4.5 Procedure and Data Collections

A. Pre-procedure:

All patients will be prepared for colonoscopy with the standard preparation and will be scheduled to have the procedure at Mayo Clinic Jacksonville. The principal investigator (PI) will screen eligible patients based on medical history, physical exam and laboratory data on day of procedure.

Patients typically arrive at the registration area at least 60 minutes before start of scheduled procedure. A GI endoscopy nurse will prepare patients in the standard manner and intravenous access will be placed. Eligible patients will be offered informed consent by the study PI or designee. Patients who agree to participate in the study will sign informed consent and will be registered in the database. A log with only non-identifiable (e.g. patients # 1) will also be maintained of eligible patients who decline to participate. The GI endoscopy nurse will monitor patient's vitals before, during and after procedure as per standard protocol.

B. Procedure:

The exams will be performed back to back with a standard colonoscope and an ETMI colonoscope provided by Olympus. The order of the first and second procedure will be randomized according to a list prepared by the statistician using randomly permuted blocks to ensure equal numbers of patients are randomized to the two groups. All patients will be sedated with meperidine or fentanyl and midazolam to achieve conscious sedation. Each procedure will be preformed by a different endoscopist. The endoscopist will be either the P.I. supervised by a GI staff physician or solely by one of the five GI staff physicians. During the initial colonoscopy all visualized polyps will be noted, photographed, and removed. When the ETMI colonoscope is used, all polyps will be photographed using these modes (HDWL, HDNBI). The NBI portion of the exam will be performed using the MB-046 cap to further enhance stabilization of the focal length of the colonoscope.

The second procedure will be done with the same level of careful inspection as the first although we not specifically regiment the time of withdrawal beyond what the endoscopist feels is necessary for a careful examination. During the second colonoscopy all visualized polyps will be noted, photographed and removed. During the first procedure, the time will be evaluated with a stopwatch. The stopwatch will start when the endoscopist begins pull-back at the cecum and end when the scope is removed from the anal verge. The clock will be stopped during washing of the bowel, polypectomy, biopsy or any other therapeutic maneuver. At the end of the first procedure, the endoscopist will be informed of the withdrawal and inspection time and every effort will be made to match this to the second procedure. Time will be recorded similarly for the second procedure. Polyps will be classified as pedunculated, raised-sessile (rounded) or flat. Flat polyps will be further classified according to the Paris endoscopic classification 14.

C. Post-procedure:

After the procedure all patients will be brought to the recovery and monitored as per standard protocol. Participants will be given discharge instructions as per protocol and also be provided with information to contact the P.I. if any problems should occur. Any post procedure complication will be reviewed on weekly intervals.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 110 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Detection and Classification of Colon Polyps: A Comparison of High Definition White Light and Narrow Band Imaging (Endoscopic Trimodal Imaging; ETMI)
Study Start Date : July 2006
Actual Primary Completion Date : December 2008
Actual Study Completion Date : December 2008

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: 2
HDNBI colonoscopy followed by standard white light colonoscopy
Procedure: Polp removal and identification
Identify polyp during colonoscopy then remove polyp
Other Name: Colonoscopy with polypectomy

Procedure: ETMI colonoscope (ETMI scope is a FDA approved device)
ETMI colonoscope used to identify colon polyps as compared to HD white light colonoscope identifying colon polyps.
Other Name: Detecting and removing colon polyps

Active Comparator: 1
standard white light colonoscopy followed by HDNBI colonoscopy
Procedure: colon polyp removal
identify and remove polyp
Other Name: Colonoscopy with polypectomy

Procedure: ETMI colonoscope (ETMI scope is a FDA approved device)
ETMI colonoscope used to identify colon polyps as compared to HD white light colonoscope identifying colon polyps.
Other Name: Detecting and removing colon polyps




Primary Outcome Measures :
  1. 1. Compare the miss rate of standard white light imaging compared to NBI for detection of colon polyps with NBI [ Time Frame: 2 years ]

Secondary Outcome Measures :
  1. 2. Estimate the accuracy of standard white light, HDWL and HDNBI imaging modes for the classification of adenomatous (premalignant) versus non-adenomatous (hyperplastic, inflammatory, normal) polyps. [ Time Frame: 2 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  1. Age 18 years or older.
  2. Informed written consent

Exclusion Criteria:

  1. History of inflammatory bowel disease.
  2. Patients with severe cardiopulmonary disease precluding colonoscopy.
  3. Presence of conditions not allowing for polypectomy or biopsy (e.g. coagulation disorder).
  4. Known familial polyposis syndrome (FAP, HNPCC, Juvenile polyposis, etc)
  5. Sub-optimal preparation for the procedure, which will be determined by patient history or based on the initial colonoscopy.
  6. Pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00825292


Locations
Layout table for location information
United States, Florida
Mayo Clinic
Jacksonville, Florida, United States, 32224
Sponsors and Collaborators
Mayo Clinic
Investigators
Layout table for investigator information
Principal Investigator: Seth A. Gross, M.D. Mayo Clinic
Principal Investigator: Michael B. Wallace, M.D. Mayo Clinic

Additional Information:
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Seth A. Gross, M.D. and Michael B. Wallace, M.D., Mayo Clinic
ClinicalTrials.gov Identifier: NCT00825292     History of Changes
Other Study ID Numbers: 06-002653 00
First Posted: January 21, 2009    Key Record Dates
Last Update Posted: January 21, 2009
Last Verified: January 2009

Keywords provided by Mayo Clinic:
colon polyps, colon adenomas

Additional relevant MeSH terms:
Layout table for MeSH terms
Polyps
Colonic Polyps
Pathological Conditions, Anatomical
Intestinal Polyps